biological api drug manufacturing market

Global Biological API Drug Manufacturing Market Research Report 2021

  • Published Date: 2021-03-30
  • Report ID: 87581
  • Pages: 103
  • Format: prudent report format

Prudent Markets Predicts that Biological API Drug Manufacturing Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Biological API Drug Manufacturing Market Overview:
Global Biological API Drug Manufacturing Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Biological API Drug Manufacturing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Biological API Drug Manufacturing Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Biological API Drug Manufacturing market in 2020.

Global Biological API Drug Manufacturing Market Segmentation
By Type, Biological API Drug Manufacturing market has been segmented into:
In-House manufacturing
Contract manufacturing

By Application, Biological API Drug Manufacturing market has been segmented into:
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Others

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Biological API Drug Manufacturing market are:
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics


1. Market Overview of Biological API Drug Manufacturing
1.1 Biological API Drug Manufacturing Market Overview
1.1.1 Biological API Drug Manufacturing Product Scope
1.1.2 Market Status and Outlook
1.2 Biological API Drug Manufacturing Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Biological API Drug Manufacturing Historic Market Size by Regions (2015-2020)
1.4 Biological API Drug Manufacturing Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Biological API Drug Manufacturing Sales Market by Type (2015-2026)
2.1 Global Biological API Drug Manufacturing Historic Market Size by Type (2015-2020)
2.2 Global Biological API Drug Manufacturing Forecasted Market Size by Type (2021-2026)
2.3 In-House manufacturing
2.4 Contract manufacturing
3. Covid-19 Impact Biological API Drug Manufacturing Sales Market by Application (2015-2026)
3.1 Global Biological API Drug Manufacturing Historic Market Size by Application (2015-2020)
3.2 Global Biological API Drug Manufacturing Forecasted Market Size by Application (2021-2026)
3.3 Monoclonal Antibody (mAb) Therapies
3.4 Vaccines
3.5 Insulin Therapies
3.6 Interferon Therapies
3.7 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Biological API Drug Manufacturing Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Biological API Drug Manufacturing Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Biological API Drug Manufacturing Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Biological API Drug Manufacturing Business
5.1 Lonza
5.1.1 Lonza Company Profile
5.1.2 Lonza Biological API Drug Manufacturing Product Specification
5.1.3 Lonza Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Boehringer Ingelheim BioXcellence
5.2.1 Boehringer Ingelheim BioXcellence Company Profile
5.2.2 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product Specification
5.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Celltrion
5.3.1 Celltrion Company Profile
5.3.2 Celltrion Biological API Drug Manufacturing Product Specification
5.3.3 Celltrion Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 DSM
5.4.1 DSM Company Profile
5.4.2 DSM Biological API Drug Manufacturing Product Specification
5.4.3 DSM Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Samsung BioLogics
5.5.1 Samsung BioLogics Company Profile
5.5.2 Samsung BioLogics Biological API Drug Manufacturing Product Specification
5.5.3 Samsung BioLogics Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Fujifilm Diosynth Biotechnologies
5.6.1 Fujifilm Diosynth Biotechnologies Company Profile
5.6.2 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product Specification
5.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Cytovance Biologics
5.7.1 Cytovance Biologics Company Profile
5.7.2 Cytovance Biologics Biological API Drug Manufacturing Product Specification
5.7.3 Cytovance Biologics Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 AbbVie
5.8.1 AbbVie Company Profile
5.8.2 AbbVie Biological API Drug Manufacturing Product Specification
5.8.3 AbbVie Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Baxter
5.9.1 Baxter Company Profile
5.9.2 Baxter Biological API Drug Manufacturing Product Specification
5.9.3 Baxter Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 CEPiA Sanofi
5.10.1 CEPiA Sanofi Company Profile
5.10.2 CEPiA Sanofi Biological API Drug Manufacturing Product Specification
5.10.3 CEPiA Sanofi Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 GSK
5.11.1 GSK Company Profile
5.11.2 GSK Biological API Drug Manufacturing Product Specification
5.11.3 GSK Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Pfizer CentreOne
5.12.1 Pfizer CentreOne Company Profile
5.12.2 Pfizer CentreOne Biological API Drug Manufacturing Product Specification
5.12.3 Pfizer CentreOne Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Sandoz
5.13.1 Sandoz Company Profile
5.13.2 Sandoz Biological API Drug Manufacturing Product Specification
5.13.3 Sandoz Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Vetter
5.14.1 Vetter Company Profile
5.14.2 Vetter Biological API Drug Manufacturing Product Specification
5.14.3 Vetter Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Wuxi Biologics
5.15.1 Wuxi Biologics Company Profile
5.15.2 Wuxi Biologics Biological API Drug Manufacturing Product Specification
5.15.3 Wuxi Biologics Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Biological API Drug Manufacturing Market Size (2015-2026)
6.2 North America Biological API Drug Manufacturing Key Players in North America (2015-2020)
6.3 North America Biological API Drug Manufacturing Market Size by Type (2015-2020)
6.4 North America Biological API Drug Manufacturing Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Biological API Drug Manufacturing Market Size (2015-2026)
7.2 East Asia Biological API Drug Manufacturing Key Players in North America (2015-2020)
7.3 East Asia Biological API Drug Manufacturing Market Size by Type (2015-2020)
7.4 East Asia Biological API Drug Manufacturing Market Size by Application (2015-2020)
8. Europe
8.1 Europe Biological API Drug Manufacturing Market Size (2015-2026)
8.2 Europe Biological API Drug Manufacturing Key Players in North America (2015-2020)
8.3 Europe Biological API Drug Manufacturing Market Size by Type (2015-2020)
8.4 Europe Biological API Drug Manufacturing Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Biological API Drug Manufacturing Market Size (2015-2026)
9.2 South Asia Biological API Drug Manufacturing Key Players in North America (2015-2020)
9.3 South Asia Biological API Drug Manufacturing Market Size by Type (2015-2020)
9.4 South Asia Biological API Drug Manufacturing Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Biological API Drug Manufacturing Market Size (2015-2026)
10.2 Southeast Asia Biological API Drug Manufacturing Key Players in North America (2015-2020)
10.3 Southeast Asia Biological API Drug Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Biological API Drug Manufacturing Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Biological API Drug Manufacturing Market Size (2015-2026)
11.2 Middle East Biological API Drug Manufacturing Key Players in North America (2015-2020)
11.3 Middle East Biological API Drug Manufacturing Market Size by Type (2015-2020)
11.4 Middle East Biological API Drug Manufacturing Market Size by Application (2015-2020)
12. Africa
12.1 Africa Biological API Drug Manufacturing Market Size (2015-2026)
12.2 Africa Biological API Drug Manufacturing Key Players in North America (2015-2020)
12.3 Africa Biological API Drug Manufacturing Market Size by Type (2015-2020)
12.4 Africa Biological API Drug Manufacturing Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Biological API Drug Manufacturing Market Size (2015-2026)
13.2 Oceania Biological API Drug Manufacturing Key Players in North America (2015-2020)
13.3 Oceania Biological API Drug Manufacturing Market Size by Type (2015-2020)
13.4 Oceania Biological API Drug Manufacturing Market Size by Application (2015-2020)
14. South America
14.1 South America Biological API Drug Manufacturing Market Size (2015-2026)
14.2 South America Biological API Drug Manufacturing Key Players in North America (2015-2020)
14.3 South America Biological API Drug Manufacturing Market Size by Type (2015-2020)
14.4 South America Biological API Drug Manufacturing Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Biological API Drug Manufacturing Market Size (2015-2026)
15.2 Rest of the World Biological API Drug Manufacturing Key Players in North America (2015-2020)
15.3 Rest of the World Biological API Drug Manufacturing Market Size by Type (2015-2020)
15.4 Rest of the World Biological API Drug Manufacturing Market Size by Application (2015-2020)
16 Biological API Drug Manufacturing Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.